Dermatologic Therapy
Scope & Guideline
Elevating dermatology with innovative insights and treatments.
Introduction
Aims and Scopes
- Clinical Efficacy of Biologics and Other Systemic Treatments:
The journal frequently publishes studies evaluating the efficacy and safety of biologic treatments for conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa, providing insights from clinical trials and real-world data. - Innovative Therapeutic Approaches:
Research on novel treatments, including the use of JAK inhibitors, biologics, and photodynamic therapy, is a core focus, showcasing advancements and new strategies in managing dermatological diseases. - Patient-Centered Outcomes and Quality of Life Assessments:
Many articles explore the impact of dermatological conditions and treatments on patients' quality of life, using patient-reported outcomes to assess treatment satisfaction and effectiveness. - Dermatological Conditions and Comorbidities:
The journal addresses the relationship between dermatological diseases and systemic conditions, highlighting the need for comprehensive management strategies that consider comorbidities. - Emerging Trends and Technologies in Dermatology:
The journal covers cutting-edge research including the application of digital solutions, teledermatology, and artificial intelligence in dermatological practice, reflecting the evolving landscape of the field.
Trending and Emerging
- Real-World Evidence and Long-Term Safety Studies:
There is an increasing trend towards publishing studies that provide real-world evidence on the long-term safety and effectiveness of treatments, particularly biologics, as practitioners seek to understand outcomes outside of clinical trial settings. - Impact of COVID-19 on Dermatology:
Research examining the effects of COVID-19 on skin conditions, treatment adherence, and the implications of vaccination on dermatological diseases has surged, reflecting the pandemic's profound impact on healthcare. - Integration of Telemedicine in Dermatology:
The rise of teledermatology as a viable option for patient care has been a notable trend, with studies exploring its effectiveness, patient satisfaction, and the management of dermatological conditions remotely. - Personalized and Targeted Therapies:
There is growing interest in personalized medicine approaches, including the use of biomarkers to predict treatment responses and tailor interventions for individual patients, particularly in the context of psoriasis and atopic dermatitis. - Psychological and Quality of Life Assessments:
An increasing number of studies are focusing on the psychological impact of skin diseases and the importance of quality of life measures, indicating a trend towards a more holistic approach to dermatological care.
Declining or Waning
- Traditional Topical Therapies:
Research on conventional topical treatments, such as corticosteroids and retinoids, has decreased as attention shifts towards systemic therapies and biologics, which are viewed as more effective for severe conditions. - Historical Case Reports:
The journal has published fewer historical case reports and anecdotal evidence, favoring robust clinical studies and systematic reviews that provide stronger evidence for treatment efficacy. - Psychodermatology Studies:
Although psychodermatology remains relevant, the frequency of studies specifically addressing the psychological aspects of dermatological conditions has waned, potentially overshadowed by more clinical and pharmacological research. - Education and Awareness Campaigns:
There appears to be a reduction in articles focused on educational initiatives and public awareness campaigns regarding skin diseases, which may be less emphasized in the current literature. - Basic Science Research:
The journal has seen a decline in the publication of basic science studies, particularly those that do not directly translate into clinical practice, as there is a stronger focus on applied research and outcomes.
Similar Journals
SKIN RESEARCH AND TECHNOLOGY
Connecting Researchers to the Frontiers of Skin Science.SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.
Annals of Dermatology
Innovating skin health through rigorous scholarship.Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.
BRITISH JOURNAL OF DERMATOLOGY
Advancing dermatological excellence since 1892.The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.
CLINICAL AND EXPERIMENTAL DERMATOLOGY
Exploring Innovations in Skin Health and Treatment.CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.
DERMATOLOGIC CLINICS
Advancing Dermatologic Knowledge for a Healthier TomorrowDERMATOLOGIC CLINICS is a leading journal in the field of dermatology, published by W B SAUNDERS CO-ELSEVIER INC. Since its inception in 1983, the journal has consistently provided a platform for the dissemination of high-quality research and clinical insights, earning its place in the prestigious Q1 quartile for dermatology in 2023. With a Scopus ranking of #34 out of 142 in its category and a commendable 76th percentile, DERMATOLOGIC CLINICS remains essential reading for clinicians, researchers, and students alike. The journal features comprehensive reviews and original articles that address the latest advancements and challenges in dermatologic diagnostics and treatments. Though it does not offer Open Access, it is widely accessible ensuring a broad readership. With a commitment to advancing the understanding of skin disorders, DERMATOLOGIC CLINICS continues to uphold its legacy of excellence in dermatological scholarship.
AUSTRALASIAN JOURNAL OF DERMATOLOGY
Empowering professionals with cutting-edge dermatological research.Australasian Journal of Dermatology is a leading publication in the field of dermatology, issued by Wiley since 1951, and reaching an audience of researchers, clinicians, and students interested in the latest advancements and practices in skin health. With an ISSN of 0004-8380 and an E-ISSN of 1440-0960, this journal stands out with its Q2 ranking in both Dermatology and Miscellaneous Medicine, positioning it within the top 61st percentile of its category according to Scopus. Although it does not provide Open Access options, Australasian Journal of Dermatology is committed to disseminating high-quality research that informs clinical practices and promotes scholarly dialogue. By publishing rigorous and peer-reviewed articles focused on various aspects of dermatological science, the journal plays a pivotal role in enhancing the dermatology community's understanding of skin conditions and treatments, making it an invaluable resource for professionals and students alike.
Journal of Cutaneous Immunology and Allergy
Transforming understanding of immune-mediated skin disorders.The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.
Actas Dermo-Sifiliograficas
Elevating Standards in Histology and Pathology ResearchActas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.
Postepy Dermatologii i Alergologii
Innovating research in Dermatology and Immunology.Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.
Current Dermatology Reports
Elevating dermatological knowledge for better patient outcomes.Current Dermatology Reports is a distinguished journal published by SPRINGER that focuses on the latest advancements and research in the field of dermatology. With an ISSN of 2162-4933, this journal provides a vital platform for clinicians, researchers, and students to disseminate groundbreaking findings and emerging trends pertinent to skin health. Notably recognized within the Q2 category in Dermatology for 2023, it ranks 50th out of 142 journals in the Scopus database, placing it in the 65th percentile among its peers. This accessible journal, which has been converging scholarly contributions since its establishment in 2012, plays a crucial role in bridging the gap between clinical practice and research, thereby enhancing patient care and advancing scientific understanding of skin-related issues. The editorial team is committed to the rigorous peer-review process, ensuring high-quality publications that reflect the evolving landscape of dermatology. Researchers and healthcare professionals are invited to contribute and engage with content that pushes the boundaries of knowledge in this dynamic discipline.